DHA Pharmacist Exam common mistakes
DHA Pharmacist Exam · Understand the traps and how to avoid them.
Answering mechanism/adverse-effect questions from drug-name recognition alone - e.g. seeing "amiodarone" and picking "hypertension" or "metformin" and picking "weight gain" without reasoning through the pharmacology.
Most candidates build vocabulary lists (brand/generic/class) during revision instead of class-level causal chains, so under time pressure they fall back on vague familiarity or the drug's most famous adverse effect rather than the one the vignette describes.
What to do instead
Build a one-page grid per drug class with four columns: mechanism → predictable adverse effect → monitoring parameter → absolute contraindication. Then drill in reverse: given the adverse effect or the monitoring lab, name the class. Do 20 reverse-lookup items daily for the two weeks before the exam.
Reading only the first sentence of a case vignette and selecting the guideline first-line drug, without screening for the details later in the stem - pregnancy, breastfeeding, eGFR, hepatic impairment, G6PD deficiency, an allergy, or an interacting co-prescription.
First-line therapy is the most strongly memorised fact in the candidate's repertoire, so it becomes an attractive answer as soon as the diagnosis is clear; the candidate treats the rest of the stem as decoration rather than as a filter that removes the obvious option.
What to do instead
Adopt a fixed 15-second pre-answer checklist applied to every case item: age/weight, pregnant or breastfeeding, renal and hepatic function, allergies, current medicines, and any 'but/except/despite' clause. Write the checklist letters on the scratch pad at the start of the exam and tick them off before looking at the options.
Computing a paediatric or renally-impairing dose by multiplying weight or creatinine clearance by the standard adult dose and stopping there - forgetting the maximum adult dose cap, the available formulation strength, or rounding to a measurable volume.
Candidates practise weight-based formulas as pure arithmetic, so the calculation feels finished once the number is produced; the clinical sanity checks (ceiling dose, roundability, formulation availability) are never rehearsed and so are never applied.
What to do instead
For every dose calculation, force four lines on the scratch pad: (1) calculated dose, (2) comparison with the maximum adult dose, (3) comparison with the concentration/strength actually stocked, (4) final measurable amount. Practise with paediatric syrups and vials, not just abstract numbers.
Treating all kinetics items as one formula bank - applying first-order half-life logic to a zero-order (saturation) drug such as phenytoin or ethanol, or assuming that doubling the dose doubles the steady-state concentration.
Revision focuses on memorising t½ = 0.693/k and Css calculations without classifying which drugs follow saturable kinetics, so the candidate recognises the numbers but not the model those numbers belong to.
What to do instead
Before any kinetics calculation, write 'zero-order or first-order?' at the top of the working. Memorise a short list of zero-order/saturable drugs (phenytoin, ethanol, high-dose salicylates, warfarin at high dose) and practise one Michaelis-Menten-style question per study session.
Answering beyond-use-date and risk-level questions for compounded sterile preparations from memory ("fridge = 14 days") without first assigning the preparation to a low, medium or high risk category and checking the storage temperature and whether it is a single-dose or multiple-dose container.
BUD tables are learned as isolated numbers, so candidates retrieve a familiar figure instead of running the decision sequence category → storage condition → container type → BUD.
What to do instead
Learn BUDs as a decision tree, not a list: state risk level aloud, then storage temperature, then container, then read off the limit. Redraw the tree from blank paper three times before the exam and answer ten BUD items using only the tree.
Selecting an antimicrobial on the basis of the organism's Gram stain or name alone, without checking the drug's spectrum - for example choosing vancomycin for a Gram-negative infection, or a macrolide for a Pseudomonas-covered indication.
Spectrum gaps are learned as lists of 'drugs that cover MRSA' rather than as a grid of Gram-positive, Gram-negative, anaerobe, atypicals and Pseudomonas, so a single salient association drives the answer.
What to do instead
Rebuild a five-column coverage grid (Gram-positive, Gram-negative, anaerobes, atypicals, Pseudomonas) with the major classes as rows, and answer every antimicrobial question by pointing to the cell the organism occupies before choosing the option.
Applying the regulatory framework of the candidate's home country - FDA scheduling, DEA controlled-drug classes, USP chapter numbers, or US prescription requirements - to questions about UAE practice; or guessing at DHA/MOHAP requirements instead of citing them.
Most widely available study material is US-generated, so the candidate's default regulatory reflex is American; UAE-specific rules receive little revision time because they are perceived as 'just local details'.
What to do instead
Create a one-page UAE regulatory sheet: UAE medical products legislation and controlled-drug scheduling, MOHAP registration and import rules, DHA facility licensing, pharmacist registration and CPD requirements, prescription retention and pharmacovigilance reporting routes. Rehearse it weekly and flag every question where you guessed the jurisdiction.
Equating statistical significance with clinical importance - choosing 'the drug works' because p < 0.05, ignoring confidence interval width, absolute versus relative risk reduction, NNT, or whether the trial had a surrogate endpoint and no blinding.
Candidates revise formulae (sensitivity, specificity, NNT) in isolation and never practise critiquing a described trial, so the interpretive judgement is untrained even when the arithmetic is correct.
What to do instead
After every abstract-style item, write three sentences: what was measured (surrogate or patient-important), how precise the estimate was (CI), and how many patients must be treated for one to benefit. Practise converting relative risk reductions in published-style summaries into absolute figures and NNT.
Confusing pharmacognosy source-organism pairs and active constituents (e.g. which Digitalis species yields digoxin, which Papaver alkaloid is which, which plant is the source of a named laxative or antimalarial) and confusing structural features with physicochemical behaviour such as pH-dependent solubility and degradation.
These facts are learned as disconnected trivia without a linking framework, so similar-sounding Latin binomials and alkaloid names collapse into each other under exam pressure.
What to do instead
Build a two-column taxonomy card per drug: source (plant/fungus, part used, family) and marker constituent. Pair each with one structural or physicochemical consequence (e.g. salt form → solubility, ester → hydrolysis). Test yourself by covering alternate columns, not by re-reading.
Losing marks to question-stem wording and pacing - missing 'EXCEPT', 'NOT', 'MOST appropriate' or 'FIRST action', and leaving the final 15 items unanswered because early calculation questions consumed the clock.
Practice is done untimed and untracked, so the candidate never builds the habit of scanning the qualifier or of abandoning an over-long item; and because every question is weighted equally, the rational time allocation strategy is never rehearsed.
What to do instead
Do at least three full-length timed mock exams under exam conditions, using a rule of two passes: answer everything straightforward on pass one, flag anything over 90 seconds, and reserve the final minutes for flagged items and a blank-answer sweep. Circle the qualifier word on the screen or scratch pad before reading the options.